Silicon Laboratories Inc.'s next confirmed earnings release is scheduled for November 4, 2026.
| Earnings Date | 11/4/2026 |
As of June 30, 2026, Silicon Laboratories Inc. has 33.37M shares outstanding.
| Shares Outstanding | 33.37M |
As of June 30, 2026, Silicon Laboratories Inc. maintains a current ratio of 5.41, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.41 |
| Quick Ratio | 3.84 |
| Interest Coverage | -10.81 |
Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. posted a negative return on equity (ROE) of -3.63, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.16, reflecting losses generated across the asset base. The company generates approximately 7.79M in revenue per employee across its workforce of 1,919.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.30 indicates how many times Silicon Laboratories Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -3.63 |
| Return on Assets (ROA) | -3.16 |
| Revenue Per Employee | 7.79M |
| Employee Count | 1,919.75 |
| Inventory Turnover | 3.30 |
Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. recorded 121.20M in income tax expense. The company reported a pretax loss of -562.10M and -683.30M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 121.20M |
As of the close on September 15, 2026, Silicon Laboratories Inc.'s stock has gained approximately 52.43% over the past 52 weeks.
| 52-Week Price Change | 52.43% |
Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. generated 14.95B in revenue and converted that into -683.30M in net income, yielding earnings per share of -20.72. EBITDA reached -174.33M, while operating income came in at -757.25M.
| Revenue | 14.95B |
| Gross Profit | 9.06B |
| Operating Income | -757.25M |
| Pretax Income | -562.10M |
| Net Income | -683.30M |
| EBITDA | -174.33M |
| EBIT | -757.25M |
| Earnings Per Share (EPS) | -20.72 |
These figures are as of June 30, 2026. Total book value stands at 19.13B, with working capital of 9.56B providing operational flexibility.
| Cash & Cash Equivalents | 6.94B |
| Net Debt | -6.33B |
| Equity (Book Value) | 19.13B |
| Book Value Per Share | 573.28 |
| Working Capital | 9.56B |
Silicon Laboratories Inc. produced 578.21M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -673.11M in capital expenditures, free cash flow totaled -94.91M - equivalent to -2.88 per share.
| Operating Cash Flow | 578.21M |
| Capital Expenditures | -673.11M |
| Free Cash Flow | -94.91M |
| FCF Per Share | -2.88 |
Over the twelve months ended June 30, 2026, Silicon Laboratories Inc. posted a gross margin of 60.61, reflecting its pricing power and cost economics. The operating margin of -5.06 and net profit margin of -4.57 provide insight into operational efficiency.
| Gross Margin | 60.61 |
| Operating Margin | -5.06 |
| Pretax Margin | -3.76 |
| Profit Margin | -4.57 |
| EBITDA Margin | -1.17 |